Simon Stertzer
Director/Board Member bij BIOCARDIA INC
Vermogen: 606 330 $ op 31-03-2024
Profiel
Simon H.
Stertzer is the founder of Vascular Science, Inc., Quantum Medical Systems, Inc., Arterial Vascular Engineering, Inc. He currently holds the position of Independent Director at BioCardia, Inc., Director at Aiva App LLC, and Professor at Stanford University School of Medicine.
He is also the Managing Member at Windrock Enterprises LLC.
In the past, he served as Chairman at Medlogics Device Corp., Director-Catheterization Laboratory at Lenox Hill Hospital, Director-Medical Research at San Francisco Heart Institute, Director at BioCardia, Inc., Director at Frontiere Algorithmic Design LLC, Cardiologist at New York University, Principal at NYU Langone Orthopedic Hospital, and Chief Medical Resident at The Bellevue Hospital.
Dr. Stertzer completed his undergraduate degree at Union College (New York) and obtained his doctorate from New York University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
BIOCARDIA, INC.
5.75% | 18-10-2023 | 1 489 754 ( 5.75% ) | 606 330 $ | 31-03-2024 |
Actieve functies van Simon Stertzer
Bedrijven | Functie | Begin |
---|---|---|
BIOCARDIA INC | Director/Board Member | - |
Windrock Enterprises LLC | Corporate Officer/Principal | 01-05-1999 |
Stanford University School of Medicine | Corporate Officer/Principal | 01-01-1998 |
Aiva App LLC | Director/Board Member | 01-01-2015 |
Eerdere bekende functies van Simon Stertzer
Bedrijven | Functie | Einde |
---|---|---|
Frontiere Algorithmic Design LLC | Director/Board Member | 01-10-2020 |
San Francisco Heart Institute
San Francisco Heart Institute Medical/Nursing ServicesHealth Services San Francisco Heart Institute operates as writing and editing company. The company is headquartered in Daly, CA. | Chief Tech/Sci/R&D Officer | 01-01-1993 |
Lenox Hill Hospital
Lenox Hill Hospital Hospital/Nursing ManagementHealth Services Lenox Hill Hospital provides health care services. It services include cardiac care, high-risk obstetrics, pediatrics, ophthalmology, orthopedics, and sports medicine. The firm's facility serves as a teaching affiliate for NYU Medical Center and also owns Manhattan Eye, Ear & Throat Hospital, a provider of specialty care for vision, hearing, speech and even swallowing disorders. The company was founded in 1857 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-01-1983 |
New York University | Corporate Officer/Principal | 01-01-1983 |
Arterial Vascular Engineering, Inc.
Arterial Vascular Engineering, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Arterial Vascular Engineering, Inc. is a private company that makes a variety of stent systems and balloon angioplasty catheters. The company is based in Santa Rosa, CA. The company was founded by Simon H. Stertzer. Arterial Vascular Engineering was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on January 28, 1999 for $3,441.52 million. | Founder | - |
Opleiding van Simon Stertzer
Union College (New York) | Undergraduate Degree |
New York University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BIOCARDIA INC | Health Technology |
Bedrijven in privébezit | 12 |
---|---|
Arterial Vascular Engineering, Inc.
Arterial Vascular Engineering, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Arterial Vascular Engineering, Inc. is a private company that makes a variety of stent systems and balloon angioplasty catheters. The company is based in Santa Rosa, CA. The company was founded by Simon H. Stertzer. Arterial Vascular Engineering was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on January 28, 1999 for $3,441.52 million. | Health Technology |
Medlogics Device Corp.
Medlogics Device Corp. Pharmaceuticals: MajorHealth Technology Medlogics Device Corp. was engages in the research, development and manufacture of drug eluting coating, stent and catheter solutions. The company was founded in August 2002 and headquartered in Santa Rosa, CA. | Health Technology |
Vascular Science, Inc.
Vascular Science, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Vascular Science, Inc. develops suture-free devices to facilitate coronary artery bypass grafting. The private company is based in Minneapolis, MN. The company was founded by Daniel J. Sullivan, Simon H. Stertzer, Rudy A. Mazzocchi. Vascular Science was acquired by St. Jude Medical LLC, part of Abbott Laboratories from January 05, 2017 on September 27, 1999 for $100 million. | Health Technology |
NYU Langone Orthopedic Hospital
NYU Langone Orthopedic Hospital Hospital/Nursing ManagementHealth Services The Hospital for Joint Diseases provides health care services for musculoskeletal and neurological disorders. Its services include orthopedics, rheumatology, neurology, rehabilitation, radiology, physical, and occupational therapy. The hospital was founded in 1905 and is headquartered in New York, NY. | Health Services |
Lenox Hill Hospital
Lenox Hill Hospital Hospital/Nursing ManagementHealth Services Lenox Hill Hospital provides health care services. It services include cardiac care, high-risk obstetrics, pediatrics, ophthalmology, orthopedics, and sports medicine. The firm's facility serves as a teaching affiliate for NYU Medical Center and also owns Manhattan Eye, Ear & Throat Hospital, a provider of specialty care for vision, hearing, speech and even swallowing disorders. The company was founded in 1857 and is headquartered in New York, NY. | Health Services |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | Health Technology |
Quantum Medical Systems, Inc. | |
The Bellevue Hospital
The Bellevue Hospital Medical/Nursing ServicesHealth Services The Bellevue Hospital provides health care services, contemporary medicine with hometown caring. The firm provides health services include diabetes education, cardiac rehab & cardiac comeback support group, cardiopulmonary care & rehabilitation, centralized scheduling, clyde health clinic, heart failure clinic, home health care, lifeline emergency phone services, northwest Ohio medical equipment company, occupational health center, plastic surgery, Rehabilitation services, and sleep disorders center. The company was founded in 1914 and is headquartered in Bellevue, OH. | Health Services |
Frontiere Algorithmic Design LLC | |
Windrock Enterprises LLC | |
Aiva App LLC | |
San Francisco Heart Institute
San Francisco Heart Institute Medical/Nursing ServicesHealth Services San Francisco Heart Institute operates as writing and editing company. The company is headquartered in Daly, CA. | Health Services |